269 related articles for article (PubMed ID: 31933458)
21. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Andrade ESN; Brandão JG; Silva JSD; Coriolano CRF; Rosa PS; Moraes MO; Ferreira CO; Gomes CM; Araújo WN
Antimicrob Agents Chemother; 2022 May; 66(5):e0217021. PubMed ID: 35435708
[TBL] [Abstract][Full Text] [Related]
22. Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
Rosa PS; D'Espindula HRS; Melo ACL; Fontes ANB; Finardi AJ; Belone AFF; Sartori BGC; Pires CAA; Soares CT; Marques FB; Branco FJD; Baptista IMFD; Trino LM; Fachin LRV; Xavier MB; Floriano MC; Ura S; Diório SM; Delanina WFB; Moraes MO; Virmond MCL; Suffys PN; Mira MT
Clin Infect Dis; 2020 May; 70(10):2054-2061. PubMed ID: 31260522
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Multidrug-Resistant
Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
[TBL] [Abstract][Full Text] [Related]
24. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
[TBL] [Abstract][Full Text] [Related]
25. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
26. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
28. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
Matsuoka M; Suzuki Y; Makino M
Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
[TBL] [Abstract][Full Text] [Related]
29. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
30. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
[TBL] [Abstract][Full Text] [Related]
31. Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
Li W; Sakamuri RM; Lyons DE; Orcullo FM; Shinde V; Dela Pena EL; Maghanoy AA; Mallari IB; Tan EV; Nath I; Brennan PJ; Balagon M; Vissa V
Antimicrob Agents Chemother; 2011 Nov; 55(11):5384-7. PubMed ID: 21859943
[TBL] [Abstract][Full Text] [Related]
32. A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries.
Matsuoka M; Aye KS; Kyaw K; Tan EV; Balagon MV; Saunderson P; Gelber R; Makino M; Nakajima C; Suzuki Y
J Med Microbiol; 2008 Oct; 57(Pt 10):1213-1219. PubMed ID: 18809547
[TBL] [Abstract][Full Text] [Related]
33. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
[TBL] [Abstract][Full Text] [Related]
34. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
35. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
37. Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?
Narang T; Kamat D; Thakur V; Lavania M; Singh I; Ahuja M; Dogra S
Clin Exp Dermatol; 2022 Feb; 47(2):297-302. PubMed ID: 34382256
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
39. A report of rifampin-resistant leprosy from northern and eastern India: identification and in silico analysis of molecular interactions.
Vedithi SC; Lavania M; Kumar M; Kaur P; Turankar RP; Singh I; Nigam A; Sengupta U
Med Microbiol Immunol; 2015 Apr; 204(2):193-203. PubMed ID: 25201810
[TBL] [Abstract][Full Text] [Related]
40. Drug-resistant M leprae.
Saunderson PR
Clin Dermatol; 2016; 34(1):79-81. PubMed ID: 26773627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
